Nwam LLC Acquires 1,409 Shares of Stryker Corporation $SYK

Nwam LLC grew its holdings in Stryker Corporation (NYSE:SYK) by 58.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 3,840 shares of the medical technology company’s stock after acquiring an additional 1,409 shares during the period. Nwam LLC’s holdings in Stryker were worth $1,488,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Norges Bank purchased a new position in Stryker during the second quarter worth $1,882,173,000. Alliancebernstein L.P. raised its position in Stryker by 307.6% in the 2nd quarter. Alliancebernstein L.P. now owns 5,596,508 shares of the medical technology company’s stock worth $2,214,146,000 after purchasing an additional 4,223,366 shares during the period. Corient Private Wealth LLC lifted its stake in Stryker by 104.4% in the second quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock worth $887,525,000 after purchasing an additional 1,146,998 shares during the last quarter. ABN AMRO Bank N.V. bought a new position in shares of Stryker during the second quarter valued at approximately $191,047,000. Finally, Vanguard Group Inc. raised its holdings in shares of Stryker by 1.3% in the second quarter. Vanguard Group Inc. now owns 33,500,571 shares of the medical technology company’s stock worth $13,253,831,000 after buying an additional 440,607 shares during the period. 77.09% of the stock is owned by institutional investors.

Insider Transactions at Stryker

In other news, CFO Preston Wendell Wells sold 165 shares of the company’s stock in a transaction dated Thursday, November 20th. The shares were sold at an average price of $365.88, for a total transaction of $60,370.20. Following the transaction, the chief financial officer owned 6,694 shares in the company, valued at $2,449,200.72. This represents a 2.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the sale, the chief accounting officer directly owned 2,833 shares in the company, valued at approximately $1,035,433.17. This represents a 40.81% decrease in their position. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 522,118 shares of company stock worth $185,381,932. Insiders own 5.90% of the company’s stock.

Stryker Trading Up 0.5%

NYSE SYK opened at $364.45 on Friday. Stryker Corporation has a 52 week low of $329.16 and a 52 week high of $406.19. The company has a 50 day moving average price of $360.20 and a 200 day moving average price of $374.07. The company has a quick ratio of 1.13, a current ratio of 1.85 and a debt-to-equity ratio of 0.68. The firm has a market cap of $139.37 billion, a PE ratio of 47.89, a price-to-earnings-growth ratio of 2.32 and a beta of 0.89.

Stryker (NYSE:SYK) last released its quarterly earnings results on Friday, October 31st. The medical technology company reported $3.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.13 by $0.06. Stryker had a net margin of 12.07% and a return on equity of 24.07%. The business had revenue of $6.06 billion for the quarter, compared to analyst estimates of $6.04 billion. During the same period in the previous year, the company earned $2.87 earnings per share. The business’s revenue for the quarter was up 10.2% on a year-over-year basis. As a group, sell-side analysts forecast that Stryker Corporation will post 13.47 EPS for the current fiscal year.

Stryker Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Wednesday, December 31st will be issued a $0.88 dividend. This is a boost from Stryker’s previous quarterly dividend of $0.84. This represents a $3.52 annualized dividend and a yield of 1.0%. The ex-dividend date of this dividend is Wednesday, December 31st. Stryker’s dividend payout ratio is 46.25%.

Analyst Upgrades and Downgrades

Several brokerages have commented on SYK. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $435.00 price objective on shares of Stryker in a research report on Friday, November 14th. UBS Group set a $408.00 price target on shares of Stryker in a research note on Monday, October 13th. Needham & Company LLC reissued a “buy” rating and issued a $448.00 price objective on shares of Stryker in a research note on Friday, November 14th. Citizens Jmp upgraded Stryker from a “market perform” rating to an “outperform” rating and set a $440.00 target price for the company in a report on Friday, December 19th. Finally, Citigroup decreased their price objective on Stryker from $455.00 to $420.00 and set a “buy” rating for the company in a report on Thursday, December 11th. Fourteen equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, Stryker has an average rating of “Moderate Buy” and an average target price of $430.00.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.